NASDAQ:MDAI Spectral AI (MDAI) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free MDAI Stock Alerts $1.85 +0.01 (+0.54%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$1.81▼$1.8950-Day Range$1.72▼$2.8352-Week Range$1.70▼$19.50Volume93,125 shsAverage Volume321,829 shsMarket Capitalization$32.32 millionP/E RatioN/ADividend YieldN/APrice Target$4.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Spectral AI alerts: Email Address Spectral AI MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside116.2% Upside$4.00 Price TargetShort InterestHealthy1.90% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.46Based on 8 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.33 out of 5 starsMedical Sector125th out of 913 stocksSurgical & Medical Instruments Industry19th out of 95 stocks 3.5 Analyst's Opinion Consensus RatingSpectral AI has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageSpectral AI has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.90% of the float of Spectral AI has been sold short.Short Interest Ratio / Days to CoverSpectral AI has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Spectral AI has recently decreased by 18.99%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSpectral AI does not currently pay a dividend.Dividend GrowthSpectral AI does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MDAI. Previous Next 2.5 News and Social Media Coverage News SentimentSpectral AI has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.32 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Spectral AI this week, compared to 2 articles on an average week.Search InterestOnly 8 people have searched for MDAI on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Spectral AI to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Spectral AI insiders have not sold or bought any company stock.Percentage Held by Insiders56.73% of the stock of Spectral AI is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions67.08% of the stock of Spectral AI is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next N/A Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Spectral AI Stock (NASDAQ:MDAI)Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.Read More MDAI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MDAI Stock News HeadlinesApril 26, 2024 | investing.comSpectral AI names new CEO for healthcare IP subsidiaryApril 26, 2024 | finance.yahoo.comSpectral AI, Inc. (MDAI)April 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 24, 2024 | finance.yahoo.comSpectral AI Schedules 2024 First Quarter Financial Results and Conference CallApril 24, 2024 | globenewswire.comSpectral AI Schedules 2024 First Quarter Financial Results and Conference CallApril 24, 2024 | proactiveinvestors.comSpectral AI appoints Erich Spangenberg as CEO of Spectral IPApril 24, 2024 | globenewswire.comSpectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that SubsidiaryApril 24, 2024 | americanbankingnews.comSpectral AI (NASDAQ:MDAI) Stock Price Up 1.1%April 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 1, 2024 | insidermonkey.comSpectral AI, Inc. (NASDAQ:MDAI) Q4 2023 Earnings Call TranscriptApril 1, 2024 | globenewswire.comSpectral AI Appoints Jeremiah Sparks as Chief Commercialization OfficerMarch 29, 2024 | seekingalpha.comSpectral AI, Inc. (MDAI) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | investorplace.comMDAI Stock Earnings: Spectral AI Beats EPS, Beats Revenue for Q4 2023March 27, 2024 | proactiveinvestors.comSpectral AI reiterates 2024 R&D revenue guidance which excludes DeepView commercialization contributionsMarch 27, 2024 | globenewswire.comSpectral AI Announces 2023 Fourth Quarter and Full Year Financial ResultsMarch 20, 2024 | proactiveinvestors.comSpectral AI announces up to $30M equity funding agreement with long-time investorMarch 20, 2024 | globenewswire.comSpectral AI Secures Access to $12.5 Million of New Equity CapitalMarch 19, 2024 | proactiveinvestors.comSpectral AI secures $1M investment in AI IP subsidiaryMarch 19, 2024 | globenewswire.comSpectral AI Announces Receipt of $1 Million of Financing for Spectral IP, Inc., its Intellectual Property Subsidiary Focused on the Broader Artificial Intelligence EcosystemMarch 14, 2024 | stockhouse.comSpectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of DeepView(TM) Wound Imaging SystemMarch 13, 2024 | globenewswire.comSpectral AI Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference CallMarch 12, 2024 | msn.comWhy Spectral AI Stock Is ClimbingMarch 12, 2024 | investorplace.comWhy Is Spectral AI (MDAI) Stock Up 15% Today?March 12, 2024 | investorplace.comWhy Is Spectral AI (MDAI) Stock Up 15% Today?March 12, 2024 | msn.comRenalytix, CareMax, TC BioPharm among healthcare moversMarch 12, 2024 | msn.comThis AI Stock Plunged 83% but Wall Street Expects a 133% Return in 2024March 12, 2024 | proactiveinvestors.comSpectral AI wins US government contract to develop handheld DeepView wound imaging systemSee More Headlines Receive MDAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Spectral AI and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/29/2024Today4/27/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:MDAI CUSIPN/A CIK1833498 Webrosecliffspac.com Phone212-492-3000FaxN/AEmployees78Year FoundedN/APrice Target and Rating Average Stock Price Target$4.00 High Stock Price Target$4.00 Low Stock Price Target$4.00 Potential Upside/Downside+116.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-20,850,000.00 Net MarginsN/A Pretax Margin-115.43% Return on EquityN/A Return on Assets-118.02% Debt Debt-to-Equity RatioN/A Current Ratio0.80 Quick Ratio0.78 Sales & Book Value Annual Sales$18.06 million Price / Sales1.79 Cash FlowN/A Price / Cash FlowN/A Book Value($0.10) per share Price / Book-18.50Miscellaneous Outstanding Shares17,470,000Free Float7,558,000Market Cap$32.32 million OptionableNot Optionable Beta0.55 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Wensheng Fan (Age 54)Co-Founder, Chief Innovation Strategist & Senior Advisor to the CEO Comp: $998.76kMr. Vincent Stanley CaponeCFO, General Counsel & Corporate SecretaryDr. Niko Pagoulatos Ph.D. (Age 50)Chief Operating Officer Comp: $383.42kMs. Christine MarksVice President of Marketing & CommercializationDr. Jeffrey Thatcher Ph.D. (Age 40)Chief Scientist Comp: $259.72kDr. Jeffrey E. Carter F.A.C.S.M.D., Chief Medical ConsultantProf. Paul ChadwickExecutive Vice President of UK & EMEAMr. Jeremiah A. Sparks MBAChief Commercialization OfficerMr. David BronsonFinancial ControllerMore ExecutivesKey CompetitorsNeuroOne Medical TechnologiesNASDAQ:NMTCModular MedicalNASDAQ:MODDFemasysNASDAQ:FEMYLucid DiagnosticsNASDAQ:LUCDCo-DiagnosticsNASDAQ:CODXView All CompetitorsInsiders & InstitutionsUniversity of Texas Texas AM Investment Managment Co.Sold 410,622 shares on 2/28/2024Ownership: 1.571%Cantor Fitzgerald L. P.Bought 15,246 shares on 2/15/2024Ownership: 0.094%Highlander Partners L.P.Bought 141,416 shares on 2/6/2024Ownership: 5.538%John Michael DimaioBought 2,000 shares on 11/20/2023Total: $5,340.00 ($2.67/share)View All Insider TransactionsView All Institutional Transactions MDAI Stock Analysis - Frequently Asked Questions Should I buy or sell Spectral AI stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Spectral AI in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MDAI shares. View MDAI analyst ratings or view top-rated stocks. What is Spectral AI's stock price target for 2024? 1 Wall Street research analysts have issued 12-month price targets for Spectral AI's shares. Their MDAI share price targets range from $4.00 to $4.00. On average, they predict the company's share price to reach $4.00 in the next year. This suggests a possible upside of 116.2% from the stock's current price. View analysts price targets for MDAI or view top-rated stocks among Wall Street analysts. How have MDAI shares performed in 2024? Spectral AI's stock was trading at $2.46 at the start of the year. Since then, MDAI shares have decreased by 24.8% and is now trading at $1.85. View the best growth stocks for 2024 here. Are investors shorting Spectral AI? Spectral AI saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 155,700 shares, a decrease of 19.0% from the March 31st total of 192,200 shares. Based on an average daily trading volume, of 1,720,000 shares, the short-interest ratio is presently 0.1 days. Approximately 1.9% of the shares of the company are sold short. View Spectral AI's Short Interest. When is Spectral AI's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our MDAI earnings forecast. How can I listen to Spectral AI's earnings call? Spectral AI will be holding an earnings conference call on Tuesday, May 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link. How were Spectral AI's earnings last quarter? Spectral AI, Inc. (NASDAQ:MDAI) posted its quarterly earnings results on Friday, March, 29th. The company reported ($0.22) earnings per share for the quarter. The company had revenue of $5.29 million for the quarter. What guidance has Spectral AI issued on next quarter's earnings? Spectral AI issued an update on its FY 2024 earnings guidance on Friday, April, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $28.0 million-$28.0 million, compared to the consensus revenue estimate of $28.1 million. How do I buy shares of Spectral AI? Shares of MDAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MDAI) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectral AI, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
